Table 2. Multivariable Logistic Regression Models with Coronary Artery Calcification Progression in Adults with Type 1 DM.
Baseline apoB (elevated ≥ 90 mg/dL or normal <90 mg/dL) Baseline nonHDL-C (elevated ≥ 130 mg/dL or normal <130 mg/dL) | |||
---|---|---|---|
CAC progression over 6-years | OR, 95% CI* | OR, 95% CI* | OR, 95% CI* |
Elevated apoB and elevated nonHDL-C (n=196) | 190 (1.15-3.15) p=0.01 | 2.86 (1.43-5.74) p=0.003 | 1.11 (0.15-8.45) p=0.92 |
Normal apoB and elevated nonHDL-C (n=10) | 1.71 (0.23-12.82) p=0.60 | 2.57 (0.33-20.28) p=0.37 | 1.00 (reference) |
Elevated apoB and normal nonHDL-C (n= 116) | 0.67 (0.35-1.26) p=0.21 | 1.00 (reference) | 0.39 (0.05-3.07) p=0.37 |
Normal apoB and normal nonHDL-C (n=330) | 1.00 (reference) | 1.50 (0.79-2.85) p=0.21 | 0.59 (0.08-4.38) p=0.60 |
Baseline apoB (at or above means ≥ 91.4 mg/dL or below means < 91.4 mg/dL) Baseline nonHDL-C (at or above means ≥ 119.0 mg/dL or below means <119.0 mg/dL) | |||
CAC progression over 6-years | OR, 95% CI* | OR, 95% CI* | OR, 95% CI* |
Above means for apoB and nonHDL-C (n=247) | 1.67 (1.04-2.67) p=0.03 | 5.24 (1.58-17.43) p=0.007 | 1.57 (0.62-3.97) p=0.34 |
Above means for nonHDL-C only (n=41) | 1.06 (0.04-2.67) p=0.90 | 3.34 (0.79-14.07) p=0.10 | 1.00 (reference) |
Above means for apoB only (n=39) | 0.32 (0.10-1.05) p=0.06 | 1.00 (reference) | 0.30 (0.07-1.26) p=0.10 |
ApoB and nonHDL-C at or below mean (n=325) | 1.00 (reference) | 3.14 (0.95-10.33) p=0.06 | 0.94 (0.38-2.36) p=0.90 |
Each column represents the same logistic regression model, but with a different reference group.
The logistic regression models are adjusted for sex, age, duration, HbA1c and statin use.
The first column reports the associations with CAC progression among the apoB and nonHDL-C groups with normal apoB and normal nonHDL-C as the reference group. The middle column represents the same model but with elevated apoB and normal HDL-C as the reference group. The last column represents the same model but with normal apoB and elevated nonHDL-C as a reference group.